Targeted therapy for NSCLC with EGFR mutations, 3rd generation EGFR-TKI, irreversible, central nervous system activity, applicable for EGFR Ex19Del or L858R mutations,
Sale!
Lucius
Replica Osimertinib EGFRm NSCLC Targeted Therapy
Original price was: $688.00.$529.00Current price is: $529.00.
Targeted therapy for NSCLC with EGFR mutations, 3rd generation EGFR-TKI, irreversible, central nervous system activity, applicable for EGFR Ex19Del or L858R mutations,
Reviews
There are no reviews yet.